Evolving Treatment Approaches for Hypertrophic Cardiomyopathy: Essential Updates for Specialty Pharmacy

Tyler J Gluckman; Martin S. Maron; Ryan J. Atkinson; Donna M. Chiefari; Judith R. Sands; Henry A. Solomon

Evolving Treatment Approaches for Hypertrophic Cardiomyopathy: Essential Updates for Specialty Pharmacy

Tyler J Gluckman
, Martin S. Maron
, Ryan J. Atkinson
, Donna M. Chiefari
, Judith R. Sands
, Henry A. Solomon

Research output: Other contribution

Abstract

Intended Audience: Managed Care Pharmacy Directors, Medical Directors, Pharmacists, and Medication Therapy Management (MTM) Nurses (pharmacists, physicians, nurses)

Tune into this recorded symposium as renowned experts in hypertrophic cardiomyopathy (HCM) and specialty pharmacy review the latest clinical developments reshaping the treatment landscape. They take a deeper dive into applications of the latest evidence on management of HCM and opportunities for specialty pharmacy to support appropriate treatment and adherence to optimize outcomes for patients with HCM.

Don't miss:

Expert insights on the latest clinical trial data impacting the HCM treatment paradigm
Case discussions in HCM

Original language	Undefined/Unknown
State	Published - Nov 1 2021

Publication series

Name	Articles, Abstracts, and Reports

Access to Document

http://digitalcommons.providence.org/publications/5399

Cite this

@misc{8b276227eb1c4d81b58b3b109be2f83c,

title = "Evolving Treatment Approaches for Hypertrophic Cardiomyopathy: Essential Updates for Specialty Pharmacy",

abstract = "Intended Audience: Managed Care Pharmacy Directors, Medical Directors, Pharmacists, and Medication Therapy Management (MTM) Nurses (pharmacists, physicians, nurses) Tune into this recorded symposium as renowned experts in hypertrophic cardiomyopathy (HCM) and specialty pharmacy review the latest clinical developments reshaping the treatment landscape. They take a deeper dive into applications of the latest evidence on management of HCM and opportunities for specialty pharmacy to support appropriate treatment and adherence to optimize outcomes for patients with HCM. Don't miss: Expert insights on the latest clinical trial data impacting the HCM treatment paradigmCase discussions in HCM",

author = "Gluckman, \{Tyler J\} and Maron, \{Martin S.\} and Atkinson, \{Ryan J.\} and Chiefari, \{Donna M.\} and Sands, \{Judith R.\} and Solomon, \{Henry A.\}",

year = "2021",

month = nov,

day = "1",

language = "Undefined/Unknown",

series = "Articles, Abstracts, and Reports",

type = "Other",

}

TY - GEN

T1 - Evolving Treatment Approaches for Hypertrophic Cardiomyopathy: Essential Updates for Specialty Pharmacy

AU - Gluckman, Tyler J

AU - Maron, Martin S.

AU - Atkinson, Ryan J.

AU - Chiefari, Donna M.

AU - Sands, Judith R.

AU - Solomon, Henry A.

PY - 2021/11/1

Y1 - 2021/11/1

N2 - Intended Audience: Managed Care Pharmacy Directors, Medical Directors, Pharmacists, and Medication Therapy Management (MTM) Nurses (pharmacists, physicians, nurses) Tune into this recorded symposium as renowned experts in hypertrophic cardiomyopathy (HCM) and specialty pharmacy review the latest clinical developments reshaping the treatment landscape. They take a deeper dive into applications of the latest evidence on management of HCM and opportunities for specialty pharmacy to support appropriate treatment and adherence to optimize outcomes for patients with HCM. Don't miss: Expert insights on the latest clinical trial data impacting the HCM treatment paradigmCase discussions in HCM

AB - Intended Audience: Managed Care Pharmacy Directors, Medical Directors, Pharmacists, and Medication Therapy Management (MTM) Nurses (pharmacists, physicians, nurses) Tune into this recorded symposium as renowned experts in hypertrophic cardiomyopathy (HCM) and specialty pharmacy review the latest clinical developments reshaping the treatment landscape. They take a deeper dive into applications of the latest evidence on management of HCM and opportunities for specialty pharmacy to support appropriate treatment and adherence to optimize outcomes for patients with HCM. Don't miss: Expert insights on the latest clinical trial data impacting the HCM treatment paradigmCase discussions in HCM

M3 - Other contribution

T3 - Articles, Abstracts, and Reports

ER -